Clinical trial
Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients
NCT04783441 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients
- Lead sponsor
- University of California, Davis
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 29, 2021
- Completion date
- December 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 2, insulin dependent diabetes, kidney transplant; complications